Rumela Chakrabarti

3PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 05, 2025
DLL1-responsive PD-L1+ tumor-associated macrophages promote endocrine resistance in breast cancer.

Shailesh Singh, Claudia Weindorfer, Ajeya Nandi

|Mar 08, 2023
Immature natural killer cells promote progression of triple-negative breast cancer.

Gatha Thacker, Samantha Henry, Ajeya Nandi

|May 19, 2018
Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche.

Rumela Chakrabarti, Toni Celià-Terrassa, Sushil Kumar

Pageof 1